FDA approves capsules to treat men's genital insufficiency

Cairo – By Mohammed Salah – Approved by the US Food and Drug Administration "FDA" Today on a drug that contains the active ingredient "Undecanoate" An oral testosterone capsule to treat men with certain forms of gonadal insufficiency.

The scientists explained that this treatment was intended for men with low levels of testosterone because of certain health problems, such as genetic disorders such as Kleinfeltr syndrome or tumors affecting the pituitary gland.

The drug should not be used in men with age-related hypothyroidism.The level of testosterone is low because of aging, even though these men have symptoms seemingly associated with low testosterone because the benefits of treatment do not outweigh the risks..

Hilton Juffi, Director of Orthopedic and Reproductive Products and Urology at the Center for Drug Evaluation and Research at Al "FDA" "Oral medicine is an important addition to the current treatment options available to men with certain types of hypothyroidism who have so far been treated with testosterone-based products applied to the skin or by injection." . "

The drug contains a warning on the labels stating that it can cause high blood pressure, increasing the risk of heart attacks, strokes and vascular problems.

The most common side effects occurred in more than 2% of patients: headache, increased hematocrit (number of red blood cells), decreased cholesterol in high density lipoprotein (HDL), hypertension and nausea .